Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment

被引：14

作者：

Zhang, Tian ^{[1
,2
]}

George, Daniel J. ^{[1
,2
]}

机构：

[1] Div Med Oncol, Dept Med, Durham, NC 27710 USA

[2] Duke Canc Inst, Ctr Prostate & Urol Canc, Durham, NC 27710 USA

来源：

NATURE MEDICINE | 2021年 / 27卷 / 04期

关键词：

RENAL-CELL CARCINOMA; PLUS AXITINIB; OPEN-LABEL; SUNITINIB; CABOZANTINIB; EFFICACY;

D O I：

10.1038/s41591-021-01320-x

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Results from the latest phase 3 clinical trial testing combinations of immunotherapy and tyrosine-kinase inhibitors for advanced kidney cancer improve standard first-line treatment options for patients.

引用

页码：586 / 588

页数：3

共 12 条

[1] Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial [J].

Albiges, Laurence ;

Tannir, Nizar M. ;

Burotto, Mauricio ;

McDermott, David ;

Plimack, Elizabeth R. ;

Barthelemy, Philippe ;

Porta, Camillo ;

Powles, Thomas ;

Donskov, Frede ;

George, Saby ;

Kollmannsberger, Christian K. ;

Gurney, Howard ;

Grimm, Marc-Oliver ;

Tomita, Yoshihiko ;

Castellano, Daniel ;

Rini, Brian, I ;

Choueiri, Toni K. ;

Saggi, Shruti Shally ;

McHenry, M. Brent ;

Motzer, Robert J. .

ESMO OPEN, 2020, 5 (06)

[2] Elements of cancer immunity and the cancer-immune set point [J].

Chen, Daniel S. ;

Mellman, Ira .

NATURE, 2017, 541 (7637) :321-330

[3] Targeting renal cell carcinoma with a HIF-2 antagonist [J].

Chen, Wenfang ;

Hill, Haley ;

Christie, Alana ;

Kim, Min Soo ;

Holloman, Eboni ;

Pavia-Jimenez, Andrea ;

Homayoun, Farrah ;

Ma, Yuanqing ;

Patel, Nirav ;

Yell, Paul ;

Hao, Guiyang ;

Yousuf, Qurratulain ;

Joyce, Allison ;

Pedrosa, Ivan ;

Geiger, Heather ;

Zhang, He ;

Chang, Jenny ;

Gardner, Kevin H. ;

Bruick, Richard K. ;

Reeves, Catherine ;

Hwang, Tae Hyun ;

Courtney, Kevin ;

Frenkel, Eugene ;

Sun, Xiankai ;

Zojwalla, Naseem ;

Wong, Tai ;

Rizzi, James P. ;

Wallace, Eli M. ;

Josey, John A. ;

Xie, Yang ;

Xie, Xian-Jin ;

Kapur, Payal ;

McKay, Renee M. ;

Brugarolas, James .

NATURE, 2016, 539 (7627) :112-+

[4] On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models [J].

Cho, Hyejin ;

Du, Xinlin ;

Rizzi, James P. ;

Liberzon, Ella ;

Chakraborty, Abhishek A. ;

Gao, Wenhua ;

Carvo, Ingrid ;

Signoretti, Sabina ;

Bruick, Richard K. ;

Josey, John A. ;

Wallace, Eli M. ;

Kaelin, William G., Jr. .

NATURE, 2016, 539 (7627) :107-+

[5] Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma [J].

Choueiri, T. K. ;

Powles, T. ;

Burotto, M. ;

Escudier, B. ;

Bourlon, M. T. ;

Zurawski, B. ;

Juarez, V. M. Oyervides ;

Hsieh, J. J. ;

Basso, U. ;

Shah, A. Y. ;

Suarez, C. ;

Hamzaj, A. ;

Goh, J. C. ;

Barrios, C. ;

Richardet, M. ;

Porta, C. ;

Kowalyszyn, R. ;

Feregrino, J. P. ;

Zolnierek, J. ;

Pook, D. ;

Kessler, E. R. ;

Tomita, Y. ;

Mizuno, R. ;

Bedke, J. ;

Zhang, J. ;

Maurer, M. A. ;

Simsek, B. ;

Ejzykowicz, F. ;

Schwab, G. M. ;

Apolo, A. B. ;

Motzer, R. J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09) :829-841

[6]

Choueiri TK, 2020, ANN ONCOL, V31, P1030, DOI [10.1016/j.annonc.2020.04.010, 10.1016/j.annoc.2020.04.010]

[7] Systemic Therapy for Metastatic Renal-Cell Carcinoma [J].

Choueiri, Toni K. ;

Motzer, Robert J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (04) :354-366

[8] Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma [J].

Motzer, Robert ;

Alekseev, Boris ;

Rha, Sun-Young ;

Porta, Camillo ;

Eto, Masatoshi ;

Powles, Thomas ;

Gruenwald, Viktor ;

Hutson, Thomas E. ;

Kopyltsov, Evgeny ;

Mendez-Vidal, Maria J. ;

Kozlov, Vadim ;

Alyasova, Anna ;

Hong, Sung-Hoo ;

Kapoor, Anil ;

Alonso Gordoa, Teresa ;

Merchan, Jaime R. ;

Winquist, Eric ;

Maroto, Pablo ;

Goh, Jeffrey C. ;

Kim, Miso ;

Gurney, Howard ;

Patel, Vijay ;

Peer, Avivit ;

Procopio, Giuseppe ;

Takagi, Toshio ;

Melichar, Bohuslav ;

Rolland, Frederic ;

De Giorgi, Ugo ;

Wong, Shirley ;

Bedke, Jens ;

Schmidinger, Manuela ;

Dutcus, Corina E. ;

Smith, Alan D. ;

Dutta, Lea ;

Mody, Kalgi ;

Perini, Rodolfo F. ;

Xing, Dongyuan ;

Choueiri, Toni K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (14) :1289-1300

[9] Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma [J].

Motzer, Robert J. ;

Hutson, Thomas E. ;

Cella, David ;

Reeves, James ;

Hawkins, Robert ;

Guo, Jun ;

Nathan, Paul ;

Staehler, Michael ;

de Souza, Paul ;

Merchan, Jaime R. ;

Boleti, Ekaterini ;

Fife, Kate ;

Jin, Jie ;

Jones, Robert ;

Uemura, Hirotsugu ;

De Giorgi, Ugo ;

Harmenberg, Ulrika ;

Wang, Jinwan ;

Sternberg, Cora N. ;

Deen, Keith ;

McCann, Lauren ;

Hackshaw, Michelle D. ;

Crescenzo, Rocco ;

Pandite, Lini N. ;

Choueiri, Toni K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) :722-731

[10] Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database [J].

Pal, Sumanta ;

Gong, Jun ;

Mhatre, Shivani K. ;

Lin, Shih-Wen ;

Surinach, Andy ;

Ogale, Sarika ;

Vohra, Rini ;

Wallen, Herschel ;

George, Daniel .

BMC CANCER, 2019, 19 (1)

← 1 2 →